Angiosarcoma Lancet Oncol 11 983?91 DOI: 10, p.20537949, 2010. ,
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas, Annals of Oncology, vol.24, issue.1, pp.257-63, 2013. ,
DOI : 10.1093/annonc/mds237
Has the time come for metronomics in low-income and middle-income countries?, The Lancet Oncology, vol.14, issue.6, pp.239-287, 2013. ,
DOI : 10.1016/S1470-2045(13)70056-1
Long-term metronomic docetaxel chemotherapy for inoperative angiosarcoma of the scalp, The Journal of Dermatology, vol.143, issue.4, pp.393-398, 2011. ,
DOI : 10.1111/j.1346-8138.2010.00988.x
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide, Anti-Cancer Drugs, vol.17, issue.8, pp.997-1005, 2006. ,
DOI : 10.1097/01.cad.0000224453.39200.d7
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors Cancer 98, p.14601096, 2003. ,
Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma, European Journal of Cancer, vol.47, issue.4, pp.515-524, 2011. ,
DOI : 10.1016/j.ejca.2010.11.025
Metronomics: towards personalized chemotherapy?, Nature Reviews Clinical Oncology, vol.41, issue.7, pp.413-31499, 2014. ,
DOI : 10.1016/j.ejca.2012.11.029
2013) ?-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer, therapy Semin Cancer Biol, vol.23, issue.6, p.24012659 ,
Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma PLoS One 8 e60021 DOI: 10, p.3610939, 2013. ,
??-Adrenergic receptor expression in vascular tumors, Modern Pathology, vol.13, issue.11, pp.1446-51 ,
DOI : 10.1016/S1470-2045(11)70318-7
??-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma, British Journal of Cancer, vol.15, issue.12, pp.2485-94 ,
DOI : 10.1056/NEJMoa0911123
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment, Oncotarget, vol.2, issue.10, pp.797-809, 2011. ,
DOI : 10.18632/oncotarget.343